Pentagon Implements Mandatory Testosterone Screening for Service Members

The Pentagon recently introduced a new policy involving mandatory testosterone screening for active-duty and reserve military personnel aged 30 and above. This decision aligns with Defense Secretary Pete Hegseth’s prior announcement that aims to optimize the natural capabilities of service members.

Hegseth emphasized the importance of maintaining strength and resilience for long-term health and operational effectiveness. The policy seeks to ensure that service members have the appropriate testosterone levels to perform at their best, not only during deployments but throughout their lives.

The new guidelines mandate testosterone blood tests for men aged 30 and older. Younger men will only undergo testing if requested or if clinicians identify warning signs. Men with low testosterone levels may receive further evaluation and potentially voluntary hormone replacement therapy.

Testosterone naturally increases during puberty and contributes to muscle strength, body hair growth, and sperm production. However, between ages 30 and 40, testosterone levels usually start to decline. Therefore, the screening focuses on those age groups to address possible deficiencies.

Women are not required to participate in routine testosterone tests but will be screened for fatigue and menstrual cycle disruptions. These symptoms can relate to hormonal issues such as low-energy availability and relative energy deficiency.

While testosterone use for non-medical purposes, especially without a doctor’s prescription, remains prohibited within the military, some guidelines allow off-label testosterone prescriptions for specific cases, including postmenopausal women experiencing low sexual desire.

There is ongoing debate among medical experts regarding the efficacy of universal testosterone screening in improving military readiness. Concerns exist over potential unnecessary or harmful treatments due to insufficient evidence supporting the claims.

The Food and Drug Administration plans to hold a meeting with experts later this month to further discuss the medical use of testosterone.